Silenseed Competitors and Similar CompaniesClear all
Silenseed's competitors and similar companies include Nektar Therapeutics, Puma Biotechnology and IDEAYA Biosciences.
 Silenseed Silenseed is a biopharmaceutical company developing RNA interference (RNAi)-based cancer drugs. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | |||
Founding Date | Founding Date 1999 | Founding Date 1990 | Founding Date 2010 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Los Angeles, US HQ | Locations South San Francisco, US HQ San Diego, US |
Employees | Employees 4 | Employees 61821% increase | Employees 27214% decrease | Employees 56 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 233.8 m | Valuation ($) 136.8 m | Valuation ($) 2.5 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $218.7m (FY, 2025) |
Net income | Net income N/A | Net income ($164.1m) (FY, 2025) | Net income N/A | Net income ($113.7m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 10.5m | Total funding raised $ 45m | Total funding raised $ 172m | Total funding raised $ 140m |
For sources of this data, please see the company profile
View Company Profiles
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyPuma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View company
IDEAYA Biosciences
HQ
South San Francisco, US
Employees
56
IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.
View company